• Following a recent pre-clinical study, Inovio have announced that their Ebola Vaccine, INO-4212 provided 100% protection following a challenge with a lethal dose of the Ebola virus.

    An article in the Journal of Infectious Diseases highlights that regimens of Inovio’s INO-4212 vaccine delivered by intramuscular administration provided 100% protection against a lethal Ebola challenge in all preclinical subjects.

    Impressively, just two injections of a simple, dose-sparing intradermal administration generated strong immunogenicity and provided 100% protection against a lethal Ebola challenge in a separate study. Scientists observed that vaccination induced long-term immune responses in monkeys that were detectable for at least one year after the final vaccination.

  • By looking at biomarkers in blood, scientists may be able to diagnose low-level opioid exposure as long as two weeks after the event, according to groundbreaking research at the U.S. Army Research, Development and Engineering Command Edgewood Chemical Biological Center (RDECOM ECBC).

    These findings, presented in a paper by research biologist Trevor Glaros, Ph.D., and his team at RDECOM ECBC, forge new ground in the field, set an innovative example and provide novel insights to guide future research. Glaros noted that the research paper was recently accepted into Toxicological Sciences, considered the most influential research journal in the field of toxicology, following a vote by its editorial board.

  • A strategic partnership will expand between the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Johnson & Johnson of New Brunswick, New Jersey.  The expansion will focus on the development of innovative products to combat the potentially deadly health effects of chemical, biological, radiation and nuclear threats, emerging infectious diseases and antimicrobial resistant infections.

  • AirBoss of America Corp. (TSX: BOS) announced today that AirBoss Defense, the defense products line of its Engineered Products segment, has been awarded the Joint Chemical Biological Radiological Nuclear General Service Respirator (J CBRN GSR) contract for the Canadian Department of National Defense (DND). AirBoss Defense will deliver critical capability in the area of Chemical, Biological, Radiological and Nuclear Defense (CBRN) to the DND by supplying up to 77,800 of its recently-commercialized Low Burden Mask (LBM) and up to 155,600 of its newly developed canister. The contract is expected to be worth up to an aggregate amount of C$29.8 Million plus any potential revenue from an 8-year in-service support contract.  Deliveries under the contract are expected to commence in 2019 and continue through 2020.

  • The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) announced today the selection of Texas A&M University to lead a consortium of U.S. academic institutions and other partners for a new Center of Excellence (COE) for Cross-Border Threat Screening and Supply Chain Defense (CBTS).  S&T will provide CBTS with a $3.85 million grant for its first operating year of a 10-year grant period.

  • Rigaku ResQ CQL offers first responders, border protection, and law enforcement with an advanced method for identifying potential threats in an improved tactical form factor, thus improving functionality particularly in high stress environments. By combining the 1064nm Raman advantage with improved ergonomics and sample presentation, ResQ CQL makes it even easier to perform chemical analysis of powders, liquids, gels, mixtures and more.

  • DroneShield announced today the release of their newest product the DroneCannon Remote Weapon (RW).

    Historically, DroneShield has focused on “soft kill” counterdrone solutions, which means that DroneShield’s products interdict drones through technological interference rather than physical kinetic impact. Military users around the world recognise that “soft kill” drone defences are particularly effective, however, they already have in service “hard kill” systems that are not drone defence-focused (a “hard kill” system is a conventional kinetic weapon that affects its target by physical impact, through bullets and other projectiles). User feedback is that many global militaries are seeking “soft kill” solutions that integrate with their existing “hard kill” systems.

  • 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, today announced the addition of a novel predictive fentanyl classifier for their MX908 multi-mission trace chemical detection device. The company will preview this new capability with law enforcement at the International Association of Chiefs of Police (IACP) 2018 conference in Orlando.

  • DARPA announced in October the launch of the Accelerated Molecular Discovery (AMD) program, which aims to develop new, AI-based systematic approaches that increase the pace of discovery and optimization of high-performance molecules. A Proposers Day webinar describing the goals of the program is scheduled for Oct.18, 2018. Details are available here: https://go.usa.gov/xPk5j

    “The ultimate goal of AMD is to speed the time to design, validate, and optimize new molecules with defined properties from several years to a few months, or even several weeks,” said Anne Fischer, program manager in DARPA’s Defense Sciences Office. “We aim to develop the AI tools, models and experimental systems to enable autonomous design of molecules to quickly meet DoD needs.”

  • Oxford Nanopore has released a new version of MinION and GridION flow cells that include the new ‘Rev D’ ASIC. The new release extends the amount of time that flow cells can be used for DNA sequencing or RNA sequencing, increasing the overall yields of DNA sequence data to as much as 30 Gb per flow cell (at this performance, the equivalent of ~10X human genome for $500*).

    The amount of sequence data that can be generated with a single flow cell has increased dramatically since the launch of nanopore sequencing technology.

  • Follow us on Twitter
  • Subscribe to CBRNe news
 
cbrne